Barclays PLC set a $56.00 price target on The Advisory Board Company (NASDAQ:ABCO) in a research note published on Tuesday. The firm currently has a buy rating on the stock.

A number of other research firms have also recently weighed in on ABCO. J P Morgan Chase & Co initiated coverage on shares of The Advisory Board Company in a report on Friday, October 28th. They set a buy rating and a $45.00 price objective on the stock. Zacks Investment Research raised shares of The Advisory Board Company from a sell rating to a hold rating in a report on Monday, November 7th. Canaccord Genuity reissued a buy rating and set a $36.00 price objective on shares of The Advisory Board Company in a report on Friday, January 13th. Robert W. Baird reissued a hold rating on shares of The Advisory Board Company in a report on Monday, February 6th. Finally, Bank of America Corporation cut shares of The Advisory Board Company from a buy rating to an underperform rating in a report on Monday, November 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have given a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus price target of $44.44.

The Advisory Board Company (NASDAQ:ABCO) opened at 47.25 on Tuesday. The Advisory Board Company has a 52-week low of $18.87 and a 52-week high of $51.23. The firm’s 50-day moving average is $42.20 and its 200-day moving average is $40.05. The firm’s market capitalization is $1.90 billion.

This piece was published by Daily Political and is the property of of Daily Political. If you are viewing this piece on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece can be accessed at http://www.dailypolitical.com/2017/02/17/barclays-plc-analysts-give-the-advisory-board-company-abco-a-56-00-price-target.html.

In related news, insider Hoose Mary Van sold 2,000 shares of The Advisory Board Company stock in a transaction on Tuesday, November 22nd. The shares were sold at an average price of $36.98, for a total value of $73,960.00. Following the transaction, the insider now directly owns 37,386 shares in the company, valued at approximately $1,382,534.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Cormac F. Miller sold 750 shares of The Advisory Board Company stock in a transaction on Wednesday, January 18th. The shares were sold at an average price of $40.53, for a total transaction of $30,397.50. Following the completion of the transaction, the insider now owns 18,237 shares in the company, valued at $739,145.61. The disclosure for this sale can be found here. Over the last quarter, insiders sold 32,884 shares of company stock worth $1,262,106. 2.90% of the stock is currently owned by insiders.

A number of institutional investors have recently bought and sold shares of the stock. Rivulet Capital LLC raised its position in The Advisory Board Company by 69.7% in the fourth quarter. Rivulet Capital LLC now owns 817,178 shares of the company’s stock worth $27,171,000 after buying an additional 335,681 shares during the period. Janus Capital Management LLC raised its position in The Advisory Board Company by 15.6% in the fourth quarter. Janus Capital Management LLC now owns 2,472,007 shares of the company’s stock worth $82,201,000 after buying an additional 332,792 shares during the period. Arrowpoint Asset Management LLC raised its position in The Advisory Board Company by 37.4% in the fourth quarter. Arrowpoint Asset Management LLC now owns 1,025,979 shares of the company’s stock worth $34,114,000 after buying an additional 279,538 shares during the period. Victory Capital Management Inc. purchased a new position in The Advisory Board Company during the third quarter worth $9,172,000. Finally, Vista Equity Partners Management LLC purchased a new position in The Advisory Board Company during the second quarter worth $6,412,000.

About The Advisory Board Company

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.